News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rolf A. Classon Joins Board of EKR Therapeutics, Inc.


5/13/2011 10:16:21 AM

BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a privately held specialty pharmaceutical company focused on providing critical care products to the hospital marketplace, has announced that Rolf A. Classon has joined the Company as Chairman of the Board.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES